Leukemia
We understand the challenges in recruiting patients with leukemia
Navigating the complex landscape of recruiting patients with leukemia for clinical trials can present significant challenges, from stringent eligibility criteria to logistical hurdles and patient doubts. At Clariness, we recognize these obstacles and are equipped to assist you in overcoming them for your study’s success.
At Clariness, we leverage over 18 years of experience in recruiting for both oncology and rare diseases. Our expertise enables us to identify and reach the right patients using effective screening techniques. Leveraging our patient platform, ClinLife®, we’ve successfully randomized over 25,000 patients to date.
years of experience in oncology and rare diseases
randomized patients to date
million people diagnosed with diabetes worldwide (2021)
Challenges when recruiting patients for diabetes studies
50% (232 million) of people with diabetes are undiagnosed (according to the International Diabetes Federation).
Therefore, it is hard to reach patients without specific outreach methods.
Newly diagnosed people often do not feel sick or in need of treatment.
Studies show that many patients (especially from minority groups) do not know about diabetes symptoms due to less access to healthcare, education, and lower socioeconomic status. Another barrier is what researchers describe as ‘Diabetes Denial,’ meaning many patients ignore mild symptoms.
Many trials do not provide patient-centric information.
Details on inclusion and exclusion criteria, the goals and procedure of the study, and other information are often not provided in a patient-centric manner. This leads to lower sign-up and participation rates, as well as higher drop-out during a clinical trial.
18-44 years of age
45-64 years of age
>65 years of age
Leukemia
What are the barriers in recruiting patients with Leukemia for clinical trials?
Recruiting patients with leukemia for clinical trials can present significant challenges due to the complex nature of the condition, on top of the usual barriers associated with every trial.
Limited patient pool:
Leukemia is relatively rare compared to other diseases, resulting in a smaller pool of eligible patients
Disease heterogeneity:
Leukemia encompasses various subtypes, each with unique genetic mutations and clinical characteristics. Finding patients who match the specific criteria for a trial can be challenging
Severity and rapid progression:
The aggressive nature of leukemia often means patients require immediate treatment, leaving little time for them to consider participating in a clinical trial
Symptom burden:
Leukemia symptoms such as fatigue, infections and bleeding can significantly impact a patient’s ability to participate in a trial, either due to physical limitations or discomfort
Access to specialized care:
Patients may need to travel long distances to access specialized leukemia treatment centers where clinical trials are conducted, posing logistical and financial challenges
How we can help
Our strategies to overcome barriers in recruiting patients with Leukemia
By focusing on the specific needs and channels frequented by patients with leukemia and their caregivers, these tailored recruitment techniques can enhance the effectiveness of patient recruitment efforts for leukemia studies.
Understanding disease dynamics
- We understand the intricacies of leukemia, including its various types and associated challenges. For instance, acute lymphoblastic leukemia (ALL) predominantly affects children, necessitating recruitment strategies tailored to pediatric oncology centers and parental support groups.
Community engagement
- We engage with leukemia patient communities through targeted outreach efforts. For instance, partnering with support groups or leukemia advocacy organizations to host informational sessions can facilitate direct access to potential study participants.
Utilizing digital platforms
- Leverage online platforms frequented by patients with leukemia and caregivers, such as disease-specific forums, social media groups or patient advocacy websites. For example, utilizing Facebook groups dedicated to leukemia support can provide a platform for disseminating study information and recruiting participants.
Clinical collaboration
- Foster collaboration with healthcare providers specializing in leukemia care to identify eligible patients. This can involve establishing referral pathways within oncology clinics or partnering with hematologists to reach potential participants receiving treatment for leukemia.
Services & Solutions
How to encourage patients with Leukemia to take part in a clinical trial?
We understand that participating in a clinical trials can offer access to cutting-edge treatments, potentially improving outcomes and quality of life, but how can you encourage patients?
Educating patients:
Provide clear information about clinical trials to help patients and caregivers make informed decisions
Building trust:
Foster open communication and transparency to overcome patient hesitancy and distrust
Reducing access barriers:
Offer remote options and language services to improve access for diverse populations
Tailoring inclusion criteria:
Collaborate with advocacy groups to ensure eligibility criteria reflect real-world patients
Engaging providers:
Educate and incentivize healthcare providers to increase patient referrals.
Utilizing Technology:
Use digital platforms to reach and engage with patients beyond traditional healthcare settings.
Services & Solutions
Want to delve deeper into how we ensure meaningful connections with patients?
At Clariness, effective patient communication is at the heart of everything we do. Whether its through our outreach strategies, study pages, screening processes, or our interactions with patients via our dedicated in-house Enrollment Success Team.
Contact us
Are you designing a Leukemia study, or have one underway?
Contact us to discover how we can support your patient recruitment.